Search

Search bills, members, committees and pages...

HB 2694

Kansas HouseIn House Committee

Summary

HB 2694, “Enacting the opioid patients right to know act to require the disclosure of the risks associated with prescribed opioid use”, was introduced in the House on Feb 4, 2026 by Rep. Alexis Simmons (D). It was referred to Health and Human Services, and last saw action on Feb 4, 2026: House Referred to Committee on Health and Human Services.


Record

Text

HB 2694 has no co-sponsors and has not gone to a roll call.

hb2694/introduced.txt
Session of 2026
HOUSE BILL No. 2694
By Representative Simmons
2-4
AN ACT concerning health and healthcare; relating to prescription
medication; enacting the opioid patients right to know act; requiring
that a healthcare provider disclose the risks of prescribed opioid use.
Be it enacted by the Legislature of the State of Kansas:
Section 1. (a) This act shall be known and may be cited as the opioid
patients right to know act.
(b) Before issuing an initial prescription of a schedule II controlled
substance pursuant to K.S.A. 65-4107, and amendments thereto, or any
other opioid pain reliever that is a prescription drug in the course of
treatment for acute or chronic pain, a prescriber shall discuss with the
patient, or the patient's parent if such patient is a minor, the risks
associated with the drugs being prescribed.
(c) The topics that the prescriber shall discuss shall include, but not
be limited to:
(1) The risk of addiction and overdose associated with opioid drugs;
(2) the dangers of taking opioid drugs with alcohol, benzodiazepines
and other central nervous system depressants;
(3) the reason that the prescription is necessary;
(4) alternative treatment that may be available; and
(5) the risks associated with the use of the drugs prescribed.
(d) The prescriber shall include a note in the patient's medical record
that such prescriber has discussed with such patient or such patient's parent
the risks of developing a physical or psychological dependence on the
schedule II controlled substance or other opioid to be prescribed and that
alternative treatment may be available.
(e) This section shall not apply to a prescription for a patient who is
currently in treatment for cancer, receiving hospice care from a licensed
hospice or palliative care or a resident of a long-term healthcare facility or
to any medications that are being prescribed for use of substance abuse or
opioid dependence.
Sec. 2. This act shall take effect and be in force from and after its
publication in the statute book.

Enacting the opioid patients right to know act to require the disclosure of the risks associated with prescribed opioid use.

Sponsors

Rep. Alexis Simmons (D) sponsors HB 2694 alone.

Committees

HB 2694 went before 1 committee: Health and Human Services.

Health and Human Services
Health and Human Services
Referred to · Feb 4, 2026 · 51 Bills

History

HB 2694 has taken 2 actions since Feb 4, 2026.

ChamberAction
Feb 4, 2026
House
House Introduced
Feb 4, 2026
House
House Referred to Committee on Health and Human Services

Votes

HB 2694 has not gone to a roll call.


Source: kslegislature.gov · legiscan.com